Generic Prescription Drugs - Your Health. Our Commitment. #Take with Confidence

The Importance of Quality and Competition

Vigorous, ethical competition is the foundation of the generic drug and biosimilar industry. AAM members develop and manufacture medicines that conform to high standards of quality, safety and efficacy as determined by regulatory authorities where they operate.

Read Statement
AAM's 2019 Access & Savings in the U.S. Report

The quality and affordability of generic medicines makes possible greater access, adherence and improved health for millions of patients across the United States.

Read Report
Generic Drugs: Take with Confidence

According to the FDA, “Generic medications are just as safe and effective as their brand-name counterparts, and often cost less.”

Learn More
Be Prepared + Get Approved

Our Justification Toolkit has everything you need to make your case for attending GRx+Biosims 2019.

Open Toolkit
Biosimilars, Biologics and Interchangeability 101

Follow along with this simple, animated white board video to learn about biosimilars, biologics, and how interchangeability can help to increase patient access while decreasing the cost of expensive medicines.

Watch Video
A Call for Session Topics

GRx+Biosims 2019 is seeking conference proposals that reflect the best thinking in the field, informed by research, expertise and experience.

Submit a Topic
Anniversary of the May 10 Trade Amendments

Twelve years ago, lawmakers prioritized patient access to affordable medicine. We can do it again and fix the USMCA!

View Infographic
NAFTA 2.0: Obstacles to More Affordable Medicines

The U.S.-Mexico-Canada Agreement (USMCA) or "NAFTA 2.0" contains obstacles to more affordable meds for Americans. There is still time to #FixUSMCA to put America’s patient first!

View Infographic
Prescription for Savings

Congress can take meaningful action to lower prescription drug costs for patients who rely on affordable medicines to live healthy lives.

Learn More
Access More Opportunity

Powered by AAM, Women in Health Policy (WiHP) is a nonpartisan network that aims to increase the number of women guiding our nation’s health care and to amplify their effectiveness and professional advancement.

Join Now

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

May 12, 2019 | Rachel Schwartz

Response to 60 Minutes May 12, 2019: AAM Statement on the Importance of Competition to Promote Accessibility and Affordability of Medicines

May 9, 2019 | AAM

2019 Generic Drug & Biosimilars Access and Savings in the U.S. Report

May 8, 2019 | Rachel Schwartz

AAM Statement on Introduction of the Affordable Prescriptions for Patients Act

May 7, 2019 | Jeff Francer

AAM Statement: Senate Judiciary Committee Hearing on Patents and Drug Prices

Apr 25, 2019 | Allen Goldberg

National Drug Take Back Day Is Saturday: Here’s What You Need to Know

Apr 24, 2019 | Jewel Smith

AAM Announces 2019 Associate Members